SCHEMBL15070985

SCHEMBL15070985

CCCCCCCCCCCCCCCC(C)CCOC1OC(CO)C(O)C(O)C1O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 1/20 0.50
MAPK1 P28482 1/20 0.50
SELL P14151 5/20 0.46
SELP P16109 5/20 0.46
SELE P16581 3/20 0.46
LGALS8 O00214 1/20 0.46
LGALS3 P17931 1/20 0.46
LGALS4 P56470 1/20 0.46
TLR4 O00206 1/20 0.44
PRKD3 O94806 1/20 0.43
PRKCG P05129 1/20 0.43
PRKCB P05771 1/20 0.43
PRKCA P17252 1/20 0.43
PRKCH P24723 1/20 0.43
PRKCI P41743 1/20 0.43
PRKCE Q02156 1/20 0.43
PRKCQ Q04759 1/20 0.43
PRKCZ Q05513 1/20 0.43
PRKCD Q05655 1/20 0.43
PRKD1 Q15139 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13576466 0.87 CETP (0.53) CETPMAPK1SELLSELPSELE
SCHEMBL18464541 0.87 CETP (0.53) CETPMAPK1SELLSELPSELE
SCHEMBL13849873 0.87 CETP (0.53) CETPMAPK1SELLSELPSELE
SCHEMBL13356315 0.87 CETP (0.53) CETPMAPK1SELLSELPSELE
SCHEMBL21537087 0.87 CETP (0.53) CETPMAPK1SELLSELPSELE
SCHEMBL12507198 0.87 CETP (0.53) CETPMAPK1SELLSELPSELE
SCHEMBL2735608 0.86 LGALS8 (0.45) LGALS8LGALS3LGALS4
SCHEMBL3564399 0.86 LGALS8 (0.45) LGALS8LGALS3LGALS4
SCHEMBL3564400 0.86 LGALS8 (0.45) LGALS8LGALS3LGALS4
SCHEMBL13576437 0.86 CETP (0.55) CETPMAPK1SELLSELPSELE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130164325-A1 CERAMIDE-LIKE GLYCOLIPID-ASSOCIATED BACTERIAL VACCINES AND USES THEREOF ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130164325-A1 CERAMIDE-LIKE GLYCOLIPID-ASSOCIATED BACTERIAL VACCINES AND USES THEREOF SGMS1, CERT1, SGMS2 CETP 82/4885MAPK1 3739/4885SELL 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.